Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA5 | P31644 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | RARB | P10826 | 1/20 | 0.37 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | MMP1 | P03956 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9517984 | 0.94 | GABRA5 (0.42) | GABRA5PTPN1MEN1NPC1RAB9A | |
| SCHEMBL9515950 | 0.92 | GABRA5 (0.40) | GABRA5PTPN1MEN1NPC1RAB9A | |
| SCHEMBL9516300 | 0.90 | GABRA5 (0.48) | GABRA5PTPN1MEN1NPC1RAB9A | |
| SCHEMBL9517031 | 0.85 | P4HTM (0.39) | GABRA5PTPN1MEN1NPC1RAB9A | |
| SCHEMBL9518142 | 0.84 | P4HTM (0.47) | GABRA5PTPN1MEN1NPC1RAB9A | |
| SCHEMBL9517187 | 0.84 | NPC1 (0.40) | GABRA5MEN1NPC1RAB9AKMT2A | |
| SCHEMBL9517918 | 0.83 | GABRA5 (0.43) | GABRA5PTPN1RARBP4HTMSMN1; SMN2 | |
| SCHEMBL9516131 | 0.83 | GABRA5 (0.40) | GABRA5SMN1; SMN2MMP1PPARG | |
| SCHEMBL9517133 | 0.83 | GABRA5 (0.42) | GABRA5PTPN1RARBP4HTMSMN1; SMN2 | |
| SCHEMBL9516988 | 0.82 | GABRA5 (0.43) | GABRA5PTPN1RARBP4HTMSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0567997-A1 | 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-11-03 | — | — | EP | disclosed |